Indeed, CAR-T-cells serve not only as killers but also as regulators that reshape the tumor microenvironment (TME) and activate both innate and adaptive immunity, producing a synergistic antitumor immunity through the release of IFN-γ [179,180]. This evidence concerns the gene IFNG and neoplasm.